We believe that elevated AM levels in early pregnancy in women who later developed gestational hypertension may be related to an increase in adrenomedullin production to counterbalance the increased production and release of vasoconstrictors such as thromboxane A2 and ET-1 from the damaged endothelium. The gene discussed is EDN1; the disease is preeclampsia.